Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



EASTLAND JULIA MARIE Create: Alert

All | News | Filings
Date FiledTypeDescription
05/31/2023 4 EASTLAND JULIA MARIE (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP
Txns: Granted 5,357 shares @ $0
Granted 22,500 options to buy @ $11.2, valued at $252k
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2023 4 EASTLAND JULIA MARIE (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 407,600 options to buy @ $0.89, valued at $362.8k
06/03/2022 4 EASTLAND JULIA MARIE (Director) has filed a Form 4 on GRAYBUG VISION, INC.
Txns: Granted 20,000 options to buy @ $0.984, valued at $19.7k
Granted 20,000 restricted stock units @ $0
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2021 4 EASTLAND JULIA MARIE (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 350,000 options to buy @ $6.85, valued at $2.4M
06/04/2021 4 EASTLAND JULIA MARIE (Director) has filed a Form 4 on GRAYBUG VISION, INC.
Txns: Granted 12,500 options to buy @ $4.07, valued at $50.9k
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2021 4/A EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $0
05/07/2021 4 EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $22.5, valued at $228.8k
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/24/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/01/2020 4 EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $20.59, valued at $209.3k
06/05/2019 4 EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $11.84, valued at $120.4k
03/29/2019 4 EASTLAND JULIA MARIE (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 5,907 options to buy @ $14, valued at $82.7k
02/07/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
03/13/2018 4 EASTLAND JULIA MARIE (CFO & CBO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Unknown transaction of 5,237 shares @ $0
Disposed/sold 6,667 options to buy @ $19.86, valued at $132.4k
Disposed/sold 8,334 options to buy @ $19.92, valued at $166k
Disposed/sold 8,334 options to buy @ $41.52, valued at $346k
Disposed/sold 8,334 options to buy @ $28.44, valued at $237k
Disposed/sold 25,000 options to buy @ $10.44, valued at $261k
Disposed/sold 16,667 options to buy @ $10.56, valued at $176k
Disposed/sold 41,667 options to buy @ $21.06, valued at $877.5k
Disposed/sold 50,000 options to buy @ $6.9, valued at $345k
Disposed/sold 51,200 options to buy @ $4.64, valued at $237.6k
Disposed/sold 75,000 options to buy @ $3.99, valued at $299.3k
02/02/2018 4 EASTLAND JULIA MARIE (CFO & CBO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Granted 199,000 options to buy @ $0
01/16/2018 4 EASTLAND JULIA MARIE (CFO & CBO) has filed a Form 4 on Cascadian Therapeutics, Inc.
Txns: Paid exercise price by delivering 923 shares @ $3.92, valued at $3.6k
Exercised 2,825 options to buy @ $0
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/19/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/12/2013 5 EASTLAND JULIA MARIE (CFO & VP Corp. Dev.) has filed a Form 5 on Oncothyreon Inc.
12/14/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
12/05/2011 4 EASTLAND JULIA MARIE (CFO & VP, CORP. DEVELOPMENT) has filed a Form 4 on Oncothyreon Inc.
Txns: Granted 50,000 options to buy @ $6.92, valued at $346k
12/03/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
11/10/2010 4 EASTLAND JULIA MARIE (CFO & VP, Corp. Development) has filed a Form 4 on Oncothyreon Inc.
Txns: Granted 40,000 options to buy @ $3.31, valued at $132.4k
09/07/2010 3 EASTLAND JULIA MARIE (CFO AND VP CORP DEVELOPMENT) has filed a Form 3 on Oncothyreon Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy